Antibody Therapeutics for Life

Notices

PharmAbcine, a clinical stage immune-oncology company, today announced that Dr. Jin-San Yoo, Chairman and Chief Executive Officer of PharmAbcine has presented as invited speaker at GBC 2018 on June 26-29, 2018
  • Written by Admin
  • Written date 2019-01-14 11:37:26
  • Inquire 1637

PharmAbcine, a clinical stage immune-oncology company, today announced that Dr. Jin-San Yoo, Chairman and Chief Executive Officer of PharmAbcine has presented as invited speaker at GBC 2018 (http://www.gbckorea.kr/) on June 26-29, 2018 and Dr. Jin-San Yoo was invited for CEO lunch forum hosted by Minister of MFDS on June 26th, 2018

 

 

For investors attending the GBC2018, please contact PharmAbcine Investor Relations and business development to schedule a meeting with management 

at sungwoo.kim@pharmabcine.com.

List





Prev PharmAbcine, a clinical stage immune-oncology company, today announced that Dr. ...
Next PharmAbcine, a clinical stage immune-oncology company, today announced that Dr. ...